Biosense Webster Launches Carto 3 Multi-Electrode Mapping System

New system provides a fast mapping, diagnoses of arrhythmias using sensor-based MEM-enabled catheters to maintain a high anatomical accuracy


August 14, 2012

August 14, 2012 — Biosense Webster Inc. launched the new Carto 3 MEM (Multi-Electrode Mapping) Version in the United States. It is the latest advancement on the Carto 3 system platform.

Based on market-leading electromagnetic technology, the new Carto 3 MEM version provides a fast method for mapping and diagnosing arrhythmias, while using sensor-based MEM-enabled catheters to maintain a high degree of anatomical accuracy. The new Pentaray Nav Catheter is equipped with an electromagnetic sensor, allowing for accurate visualization of electrode position on the Carto 3 system and higher resolution signals.

"Multi-electrode mapping represents a significant advancement in mapping technology, allowing physicians to acquire multiple mapping points simultaneously with a high level of detail and Carto 3 system accuracy," said Vivek Reddy, M.D., Mount Sinai School of Medicine. "Combined with the new Pentaray Nav Catheter, you can reduce the number of required catheter maneuvers to quickly diagnose any arrhythmia. This further supports the safety, effectiveness and efficiency of cardiac ablation procedures for patients."

Reddy is compensated for his services as a member of the company's scientific advisory board and provides other consulting services.

For more information: